Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BINC-B: Imaging and Biomarkers in Neoadjuvant Breast Cancer
NCT03242551Phase 2Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- Nov 2017
- Primary completion
- Aug 2022
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of epirubicin, cyclophosphamide, paclitaxel, trastuzumab in breast cancer, sponsored by Shenzhen People's Hospital. Status: unknown.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03242551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242551.